Officials from Vertex Pharmaceuticals and CRISPR Therapeutics have announced that preliminary results from testing CRISPR gene-editing treatment in human patients with blood disorders show promise thus far. The joint project ...
The hormone erythropoietin (Epo) is a well-known doping substance that has a long history of abuse in endurance sports such as cycling. In addition to promoting red blood cell production (erythropoiesis), which improves the ...
Oct 28, 2019
0
60
Malaria is one of the world's deadliest infectious diseases: a small mosquito bite delivers numerous malaria parasites into the bloodstream. The human body defends itself valiantly against the parasite, which usually results ...
Oct 21, 2019
0
42
Most people have some idea of how important iron is to their health, but Iqbal Hamza, professor in Animal and Avian Sciences, has made his seventeen-year career at the University of Maryland all about the study of iron and ...
Oct 1, 2019
0
28
Researchers from BioPRIA, based at Australia's Monash University, together with industry partner Haemokinesis, have developed the world's first blood incubator using laser technology. This could prevent fatal blood transfusions ...
Sep 20, 2019
0
29
Breakthrough research has revealed a new drug that may prevent the spread of malaria, and also treat people suffering with the deadly parasitic disease.
Aug 30, 2019
0
106
Researchers at the University of Bristol and Imperial College London have established a new model system that uses red blood cells grown in the laboratory to study how malaria parasites invade red blood cells.
Aug 29, 2019
0
36
A team of Brown University researchers has developed a new computer model that simulates the way red blood cells become misshapen by sickle cell disease. The model, described in a paper published in Science Advances, could ...
Aug 22, 2019
0
24
Rapamycin, a drug widely used to protect organ transplant patients, eased symptoms of β-thalassemia in mice and showed promise for treatment of humans with the inherited disorder, researchers reported. St. Jude Children's ...
Aug 22, 2019
0
97
In a paper published in the July 31 issue of Science Translational Medicine, researchers at Fred Hutchinson Cancer Research Center used CRISPR-Cas9 to edit long-lived blood stem cells to reverse the clinical symptoms observed ...
Jul 31, 2019
0
87
